BEUDAMED
    FDA Adverse Event Injury Summary report: N

    API 50 CHL MEDIUM 10X10ML ®

    MDR report key: 17910898 · Received October 11, 2023

    Report

    Report Number
    9615754-2023-00043
    Event Type
    Injury
    Date Received
    October 11, 2023
    Report Date
    October 25, 2023
    Manufacturer
    BIOMERIEUX, SA
    Product Code
    JSC
    UDI-DI
    03573026087456
    PMA / PMN Number
    EXEMPT
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    JA
    Reporter Occupation
    OTHER HEALTH CARE PROFESSIONAL
    Health Professional
    Yes

    Narratives

    Additional Manufacturer Narrative · 0

    CONTEXT: A CUSTOMER REPORTED AN OPERATOR INJURY DURING THE INOCULATION OF API 50 CH STRIP. THE BACTERIAL SUSPENSION WAS PREPARED IN API 50 CHL MEDIUM (REFERENCE (B)(4)). THEN, DURING THE INOCULATION OF THIS SUSPENSION IN THE API 50 CH STRIP (REFERENCE (B)(4)), THE TIP OF THE PIPETTE (REFERENCE (B)(4)) HIT THE STRIP AND BOUNCED, CAUSING THE SUSPENSION TO ACCIDENTALLY SPLASH INTO THE OPERATOR EYES. THE OPERATOR WAS NOT WEARING GOGGLES AND DID NOT WASH THEIR EYES IMMEDIATELY. THE NEXT DAY, THE OPERATOR WENT TO AN OPHTHALMOLOGIST BECAUSE SHE DEVELOPED CONJUNCTIVITIS AND SWELLING IN HER EYES. INVESTIGATION RESULTS: **COMPLAINT ANALYSIS** THE REVIEW OF THE COMPLAINT DID NOT INDICATE ANY SYSTEMATIC QUALITY ISSUE RELATED TO THIS INVESTIGATION. **REVIEW OF THE PACKAGE INSERT** THE PACKAGE INSERT 07486 I (RELATED TO API 50 CHL MEDIUM) AND 07945 H (RELATED TO API 50 CH PRODUCT) HAVE A PARAGRAPH "WARNING AND PRECAUTION" WHICH MENTIONED PARTICULARLY THE FOLLOWING : FOR PROFESSIONAL USE ONLY. THIS TEST IS INTENDED FOR USE BY TRAINED LABORATORY PROFESSIONALS. THIS KIT CONTAINS PRODUCTS OF ANIMAL ORIGIN. CERTIFIED KNOWLEDGE OF THE ORIGIN AND/OR SANITARY STATE OF THE ANIMALS DOES NOT TOTALLY GUARANTEE THE ABSENCE OF TRANSMISSIBLE PATHOGENIC AGENTS. IT IS THEREFORE RECOMMENDED THAT THESE PRODUCTS BE TREATED AS POTENTIALLY INFECTIOUS, AND HANDLED OBSERVING THE USUAL SAFETY PRECAUTIONS (DO NOT INGEST; DO NOT INHALE). ALL SPECIMENS, MICROBIAL CULTURES AND INOCULATED PRODUCTS SHOULD BE CONSIDERED INFECTIOUS AND HANDLED APPROPRIATELY. ASEPTIC TECHNIQUE AND USUAL PRECAUTIONS FOR HANDLING THE BACTERIAL GROUP STUDIED SHOULD BE OBSERVED THROUGHOUT THIS PROCEDURE. REFER TO "CLSI M29-A, PROTECTION OF LABORATORY WORKERS FROM OCCUPATIONALLY ACQUIRED INFECTIONS; APPROVED GUIDELINE - CURRENT REVISION". FOR ADDITIONAL HANDLING PRECAUTIONS, REFER TO "BIOSAFETY IN MICROBIOLOGICAL AND BIOMEDICAL LABORATORIES - CDC/NIH - LATEST EDITION", OR TO THE REGULATIONS CURRENTLY IN USE IN EACH COUNTRY. THEREBY, THE INFORMATION MENTIONED IN THESE PACKAGE INSERTS ARE NOT QUESTIONED. CONCLUSION: NO SYSTEMATIC QUALITY ISSUE HAS BEEN IDENTIFIED DURING THE INVESTIGATION. THE REPORTED ISSUE IS LINKED TO AN USER ERROR DURING THE TESTS PERFORMED BY THE USER. THE PACKAGE INSERTS MENTIONED THE NECESSARY WARNING AND PRECAUTIONS NEEDED FOR THE MANIPULATION OF THE REFERENCED PRODUCT.

    Description of Event or Problem · 0

    INTENDED USE: API® 50 CHL MEDIUM, INTENDED FOR THE IDENTIFICATION OF THE GENUS LACTOBACILLUS AND RELATED GENERA, IS A READY-TO-USE MEDIUM WHICH ALLOWS THE STUDY OF THE FERMENTATION OF THE 49 CARBOHYDRATES ON THE API® 50 CH STRIP. PRINCIPLE OF USE: A SUSPENSION IS PREPARED IN THE MEDIUM WITH THE MICROORGANISM TO BE TESTED AND EACH TUBE OF THE STRIP IS THEN INOCULATED WITH THE SUSPENSION. DURING INCUBATION, THE CARBOHYDRATES ARE FERMENTED TO ACIDS WHICH PRODUCE A DECREASE IN THE PH,DETECTED BY THE CHANGE IN COLOR OF THE INDICATOR. THE RESULTS MAKE UP THE BIOCHEMICAL PROFILE WHICH IS USED BY THE IDENTIFICATION SOFTWARE TO IDENTIFY THE STRAIN. DESCRIPTION OF THE ISSUE: A CUSTOMER IN JAPAN NOTIFIED BIOMÉRIEUX OF AN OPERATOR INJURY CAUSED BY THE API 50 CHL MEDIUM 10X10ML - REFERENCE 50410 (LOT NOT SPECIFIED) WHEN MANIPULATING THE PRODUCT. INDEED, THE CUSTOMER INDICATES THEY WERE USING A PIPETTE TO INJECT THE API 50 CHL MEDIUM INTO THE API50CH KIT WHEN THE TIP OF THE PIPETTE HIT THE KIT AND BOUNCED, CAUSING THE MEDIUM TO SPLASH INTO THEIR EYES. THE CUSTOMER WAS NOT WEARING GOGGLES AND DID NOT WASH THEIR EYES IMMEDIATELY. THE NEXT DAY, THE CUSTOMER WENT TO AN OPHTHALMOLOGIST BECAUSE THEY DEVELOPED CONJUNCTIVITIS AND SWELLING IN THE EYES. BIOMÉRIEUX HAS BEEN INFORMED THAT SYMPTOMS HAVE IMPROVED AFTER BEING PRESCRIBED EYE DROPS. THERE IS NO INDICATION OR REPORT FROM THE CUSTOMER THAT THE SYMPTOMS HAVE BEEN COMPLETELY RESOLVED. THIS EVENT HAS BEEN REVIEWED FOR VIGILANCE REPORTING IN ACCORDANCE WITH 21 CFR 803, CONCERNING MEDICAL DEVICE REPORTING. THIS REVIEW HAS DETERMINED THAT THIS EVENT MEETS THE CRITERIA FOR REPORTING AS AN OPERATOR INJURY OCCURED. THE USER DID NOT WEAR ANY GOGGLES, CONTRIBUTING TO THE HAZARDOUS SITUATION THAT HAS LED TO THE INJURY. A BIOMÉRIEUX INTERNAL INVESTIGATION WILL BE INITIATED.

    Description of Event or Problem · 0

    INTENDED USE: API® 50 CHL MEDIUM, INTENDED FOR THE IDENTIFICATION OF THE GENUS LACTOBACILLUS AND RELATED GENERA, IS A READY-TO-USE-MEDIUM WHICH ALLOWS THE STUDY OF THE FERMENTATION OF THE 49 CARBOHYDRATES ON THE API® 50 CH STRIP. PRINCIPLE OF USE: A SUSPENSION IS PREPARED IN THE MEDIUM WITH THE MICROORGANISM TO BE TESTED AND EACH TUBE OF THE STRIP IS THEN IN OCULATED WITH THE SUSPENSION. DURING INCUBATION, THE CARBOHYDRATES ARE FERMENTED TO ACIDS WHICH PRODUCE A DECREASE IN THE PH,DETECTED BY THE CHANGE IN COLOR OF THE INDICATOR. THE RESULTS MAKE UP THE BIOCHEMICAL PROFILE WHICH IS USED BY THE IDENTIFICATION SOFTWARE TO IDENTIFY THE STRAIN. DESCRIPTION OF THE ISSUE: A CUSTOMER IN JAPAN NOTIFIED BIOMERIEUX OF AN OPERATOR INJURY CAUSED BY THE API 50 CHL MEDIUM 10X10ML REFERENCE 50410 (LOT NOT SPECIFIED) WHEN MANIPULATING THE PRODUCT. INDEED, THE CUSTOMER INDICATES THAT HE WAS USING AN APIPIPETTE TO INJECT THE API 50 CHL MEDIUM INTO THE API50CH KIT WHEN THE TIP OF THE PIPETTE HIT THE KIT AND BOUNCED, CAUSING THE MEDIUM TO SPLASH INTO HER EYES. THE CUSTOMER WAS NOT WEARING GOGGLES AND DID NOT WASH THEIR EYES IMMEDIATELY. THE NEXT DAY, THE CUSTOMER WENT TO AN OPHTHALMOLOGIST BECAUSE HE DEVELOPED CONJUNCTIVITIS AND SWELLING IN HER EYES. BIOMÉRIEUX HAS BEEN INFORMED THAT SYMPTOMS HAVE IMPROVED AFTER BEING PRESCRIBED EYE DROP. THERE IS NO INDICATION OR REPORT FROM THE CUSTOMER THAT THE SYMPTOMS HAVE BEEN COMPLETELY RESOLVED. THIS EVENT HAS BEEN REVIEWED FOR VIGILANCE REPORTING IN ACCORDANCE WITH 21 CFR 803, CONCERNING MEDICAL DEVICE REPORTING. THIS REVIEW HAS DETERMINED THAT THIS EVENT MEETS THE CRITERIA FOR REPORTING AS AN OPERATOR INJURY OCCURED. THE USER DID NOT WEAR ANY GOGGLES CONTRIBUTING TO THE HAZARDOUS SITUATION THAT HAS LED TO THE INJURY. A BIOMÉRIEUX INTERNAL INVESTIGATION WILL BE INITIATED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    2083963 API 50 CHL MEDIUM 10X10ML ® API 50 CHL MEDIUM 10X10ML® JSC BIOMERIEUX, SA 03573026087456

    Patients

    Seq Age Sex Outcome Treatment
    1 Unknown Required Intervention